Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fennec Pharmaceuticals Inc
(NQ:
FENC
)
5.560
-0.020 (-0.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Highlighted for Surprising Price Action
March 18, 2024
Via
Investor Brand Network
Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Making Surprising Moves in Monday Session
November 06, 2023
Via
Investor Brand Network
NASDAQ:FENC Long Term Shareholder Notice: Investigation over Possible Wrongdoing at Fennec Pharmaceuticals Inc.
June 01, 2022
San Diego, CA -- (SBWIRE) -- 06/01/2022 -- Certain directors of Fennec Pharmaceuticals Inc. are under investigation over potential breaches of fiduciary duties.
Via
SBWire
NASDAQ:FENC Shareholder Notice: Deadline on April 11, 2022 in Lawsuit Against Fennec Pharmaceuticals Inc.
April 11, 2022
San Diego, CA -- (SBWIRE) -- 04/11/2022 -- A deadline is coming up on April 11, 2022 in the lawsuit filed for certain investors of Fennec Pharmaceuticals Inc. (NASDAQ:FENC).
Via
SBWire
FENC Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Last Few Hours to Contact the Firm
April 11, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
FENC FINAL DEADLINE APRIL 11: NATIONALLY RANKED ROSEN LAW FIRM Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - FENC
April 09, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)
April 08, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FENC
April 04, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FENC
March 11, 2022
WHY: NEW YORK, NY - (NewMediaWire) - March 11, 2022 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENC
March 04, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Investor Notice: Lawsuit Alleges Violations of Securities Laws
February 24, 2022
San Diego, CA -- (SBWIRE) -- 02/24/2022 -- An investor, who purchased NASDAQ:FENC shares, filed a lawsuit against Fennec Pharmaceuticals Inc. over alleged violations of Federal Securities Laws.
Via
SBWire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)
February 22, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
Kirby McInerney LLP Investors That a Class Action Lawsuit Has Been Filed on Behalf of Fennec Pharmaceuticals Inc. (FENC) Investors and Encourages Investors to Contact the Firm Before April 11, 2022
February 18, 2022
From
Kirby McInerney LLP
Via
Business Wire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)
February 18, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Fennec Pharmaceuticals Inc. (FENC) Investors
February 16, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Fennec Pharmaceuticals Inc. (FENC) Investors
February 15, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Fennec Pharmaceuticals Inc. (FENC) Investors
February 14, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Shareholder Alert: Robbins LLP Reminds Investors That Fennec Pharmaceuticals Inc. (FENC) is Being Sued for Misleading Shareholders
February 14, 2022
From
Robbins LLP
Via
Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action FENC
February 12, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
FENNEC ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Fennec Pharmaceuticals Inc. and Encourages Investors to Contact the Firm
February 11, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fennec Pharmaceuticals Inc. (FENC) on Behalf of Investors
February 11, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fennec Pharmaceuticals Inc. (FENC) on Behalf of Investors
February 11, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Fennec Pharmaceuticals Inc. (FENC) Investors
February 11, 2022
From
Kirby McInerney LLP
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors that Fennec Pharmaceuticals Inc. (FENC) is Being Sued for Misleading Shareholders
February 11, 2022
From
Robbins LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Fennec Pharmaceuticals Inc. (FENC) on Behalf of Investors
February 10, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FENC
February 10, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Fennec Pharmaceuticals Inc. (FENC) Investors of Investigation
February 10, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Investor Notice: Investigation over Possible Violations of Securities Laws
December 16, 2021
San Diego, CA -- (SBWIRE) -- 12/16/2021 -- An investigation for investors in Fennec Pharmaceuticals Inc. (NASDAQ: FENC) shares over potential securities laws violations by Fennec Pharmaceuticals Inc....
Via
SBWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.